Epidemiology
Upcoming SlideShare
Loading in...5
×
 

Epidemiology

on

  • 616 views

 

Statistics

Views

Total Views
616
Views on SlideShare
616
Embed Views
0

Actions

Likes
0
Downloads
13
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Epidemiology Epidemiology Document Transcript

    • Epidemiology: COPD – Aging population and stable smoking rates to raise casenumbersReportsnReports.com adds Datamonitor Research Market Research Report “Google MarketIntelligence ’’ to its store.In 2010, Datamonitor estimates that there were about 69.5 million total prevalent cases ofchronic obstructive pulmonary disease (COPD) in people aged over 40 in the seven majormarkets(the US, Japan, France, Germany, Italy, Spain, and the UK). Approximately 54% ofcases were mild, 38% were moderate, and 8% were severe or very severe.Features and benefits Gain insight into market potential, including a robust 10-year epidemiology forecast of chronic obstructive pulmonary disease prevalent cases. Understand the key epidemiologic risk factors associated with chronic obstructive pulmonary disease.HighlightsBetween 2010 and 2020, Datamonitor expects to see a significant increase in the number oftotal prevalent cases of COPD in those over age 40 in the seven major markets (the US,Japan, France, Germany, Italy, Spain, and the UK), from 69.5 million cases to 79.5 millioncases. The largest increase will be in the US and the smallest in Germany.Datamonitor estimates that the largest number of cases of COPD will be in those over age70, especially in men, due to the fact that COPD prevalence rates increase with age andmen are more likely to be smokers. Of the prevalent cases, 11% will be in those aged 40–49, 21% in those aged 50–59, 25% in those aged 60–69, and 42% in those aged over 70.Datamonitor estimates that in 2010, the majority of COPD cases in the seven majormarkets (the US, Japan, France, Germany, Italy, Spain, and the UK) were mild cases.Approximately 54% of cases were mild, 38% were moderate, and 8% were severe or verysevere.Your key questions answered What are the most robust sources for chronic obstructive pulmonary disease prevalence data? How will the patient population change through to 2020 in the US, Japan, and the five major EU markets (France, Germany, Italy, Spain, and the UK)? How do changes in population structure and risk factors affect the trend in prevalent chronic obstructive pulmonary disease cases?Table Of ContentsExecutive SummaryEpidemiology of COPDCOPD in the seven major marketsDatamonitor’s forecast of COPD
    • OVERVIEWCatalystSummaryDISEASE DEFINITION AND DIAGNOSTIC CRITERIACOPD backgroundSpirometry is the gold standard for diagnosing COPDClassification of COPDGLOBAL VARIATION AND HISTORICAL TRENDSCOPD is significantly underdiagnosed worldwideTrends in COPD incidence and prevalence rates are driven by smoking ratesCOPD causes significant morbidity and mortality worldwideMorbidityMortalityDRIVERS OF COPD EPIDEMIOLOGYRisk factorsAge is one of the leading risk factors in COPDHigh male prevalence rates of COPD are related to other increased risk factors in malesTobacco smoke is the leading risk factor of COPDGenetics are related to susceptibility in COPDOccupational exposures and other air pollutants increase risk of COPDCo-morbid conditionsAsthma and COPD can be confused in diagnosisPulmonary and respiratory infection are common exacerbations in COPDCardiovascular co-morbidities are related to similar risk factors between the two diseasesPulmonary hypertension prevalence increases with severity of COPDPatients with COPD are at a significantly increased risk of lung cancerOsteoporosis and the number of fractures are much higher in those with COPDEPIDEMIOLOGIC FORECASTING OF COPDOverviewSubpopulationsAge and genderSeverityUSSources usedMethodsSources not usedJapanSources usedMethodsSources not usedFranceSources usedMethodsSources not usedGermany
    • Sources usedMethodsSources not usedItalySources usedMethodsSources not usedSpainSources usedMethodsSources not usedUKSources usedMethodsSources not usedEPIDEMIOLOGIC RESULTSCurrent prevalent cases and future trends of COPDSeverityAge and genderAge-standardized prevalence ratesDISCUSSIONStrengths and limits of Datamonitor’s epidemiologic projectionsConclusionsBIBLIOGRAPHYJournal papersWebsitesDatamonitor reportsAPPENDIXModule methodologyLatest Market Research Reports: Middleware Messaging Market World Power Lawn & Garden Equipment Epidemiology: COPD – Aging population and stable smoking rates to raise case numbers Hot Topics in Type 2 Diabetes: Complications and Comorbidities – Physician insight on diabetic complications, comorbidities and treatment Market and Product Forecasts: Systemic Lupus Erythematosus – Benlysta approval kicks off new era in lupus treatment UK Mortgages 2011: Competitive Dynamics in the UK Mortgage Market UK Private Medical Insurance 2011 Energy Efficiency Opportunities in the B2B Sector – Europe
    • About Us:ReportsnReports is an online library of over 75,000 market research reports and in-depthmarket research studies & analysis of over 5000 micro markets. We provide 24/7 online andoffline support to our customers. Get in touch with us for your needs of market researchreports.Follow us on Twitter: http://twitter.com/marketsreportsOur Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689Contact:Mr. Priyank7557 Rambler road,Suite 727, Dallas, TX 75231Tel: + 1 888 391 5441E-mail: sales@reportsandreports.comhttp://www.reportsnreports.comVisit Our Market Research Blog